Cargando…

Erratum. Impact of Lifestyle and Metformin Interventions on the Risk of Progression to Diabetes and Regression to Normal Glucose Regulation in Overweight or Obese People With Impaired Glucose Regulation. Diabetes Care 2017;40:1668–1677

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Herman, William H., Pan, Qing, Edelstein, Sharon L., Mather, Kieren J., Perreault, Leigh, Barrett-Connor, Elizabeth, Dabelea, Dana M., Horton, Edward, Kahn, Steven E., Knowler, William C., Lorenzo, Carlos, Pi-Sunyer, Xavier, Venditti, Elizabeth, Ye, Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2018
Materias:	Errata
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5860847/ https://www.ncbi.nlm.nih.gov/pubmed/29475844 http://dx.doi.org/10.2337/dc18-er04

Ejemplares similares

Erratum. Impact of lifestyle and metformin interventions on the risk of progression to diabetes and regression to normal glucose regulation in overweight or obese people with impaired glucose regulation. Diabetes Care 2017;40:1668—1677
por: Herman, William H., et al.
Publicado: (2019)

Erratum. Basal Glucose Can Be Controlled, but the Prandial Problem Persists—It’s the Next Target! Diabetes Care 2017;40:291–300
por: Riddle, Matthew C.
Publicado: (2017)

Erratum. Maternal BMI and Glycemia Impact the Fetal Metabolome. Diabetes Care 2017;40:902–910
por: Lowe, William L., et al.
Publicado: (2018)

Erratum. Diabetic Retinopathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017;40:412–418
por: Solomon, Sharon D., et al.
Publicado: (2017)

Erratum. The virtual office visit for women with gestational diabetes mellitus. Diabetes Care 2017;40:e34—e35
por: Sacks, David A., et al.
Publicado: (2019)

Erratum. Risk of Severe Hypoglycemia in Type 1 Diabetes Over 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2017;40:1010–1016
por: Gubitosi-Klug, Rose A., et al.
Publicado: (2021)

Erratum. Time Trends of Dietary and Lifestyle Factors and Their Potential Impact on Diabetes Burden in China. Diabetes Care 2017;40:1685–1694
por: Li, Yanping, et al.
Publicado: (2018)

Erratum. Diabetes Care in the Hospital. Sec. 14. In Standards of Medical Care in Diabetes—2017. Diabetes Care 2017;40(Suppl. 1);S120–S127
Publicado: (2017)

Erratum. Intensive Versus Standard Blood Pressure Control in SPRINT-Eligible Participants of ACCORD-BP. Diabetes Care 2017;40:1733–1738
por: Buckley, Leo F., et al.
Publicado: (2018)

Erratum. Cardiovascular Disease and Type 2 Diabetes: Has the Dawn of a New Era Arrived? Diabetes Care 2017;40:813–820
por: Abdul-Ghani, Muhammad, et al.
Publicado: (2017)

Erratum. Glycemic Targets. Sec. 6. In Standards of Medical Care in Diabetes—2017. Diabetes Care 2017;40(Suppl. 1);S48–S56
Publicado: (2017)

Erratum. Metformin Use in Prediabetes Among U.S. Adults, 2005–2012. Diabetes Care 2017;40:887–893
por: Tseng, Eva, et al.
Publicado: (2018)

Erratum. Factors Associated With Diabetes-Specific Health-Related Quality of Life in Youth With Type 1 Diabetes: The Global TEENs Study. Diabetes Care 2017;40:1002—1009
por: Anderson, Barbara J., et al.
Publicado: (2018)

Erratum. Microvascular Complications and Foot Care. Sec. 10. In Standards of Medical Care in Diabetes—2017. Diabetes Care 2017;40(Suppl. 1);S88–S98
Publicado: (2017)

Erratum. Pharmacologic Approaches to Glycemic Treatment. Sec. 8. In Standards of Medical Care in Diabetes—2017. Diabetes Care 2017;40(Suppl. 1);S64–S74
Publicado: (2017)

Erratum. Comprehensive Medical Evaluation and Assessment of Comorbidities. Sec. 3. In Standards of Medical Care in Diabetes—2017. Diabetes Care 2017;40(Suppl. 1);S25–S32
Publicado: (2017)

Erratum. Accuracy of 1-Hour Plasma Glucose During the Oral Glucose Tolerance Test in Diagnosis of Type 2 Diabetes in Adults: A Meta-analysis. Diabetes Care 2021;44:1062–1069
por: Ahuja, Vasudha, et al.
Publicado: (2021)

Erratum. Dipeptidyl Peptidase 4 Inhibition Stimulates Distal Tubular Natriuresis and Increases in Circulating SDF-1α(1-67) in Patients With Type 2 Diabetes. Diabetes Care 2017;40:1073–1081
por: Lovshin, Julie A., et al.
Publicado: (2017)

Regression From Pre-Diabetes to Normal Glucose Regulation in the Diabetes Prevention Program
por: Perreault, Leigh, et al.
Publicado: (2009)

Erratum. Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study. Diabetes Care 2017;40:325–331
por: Abdul-Ghani, Muhammad, et al.
Publicado: (2017)

Erratum. Response to Comment on Pathak et al. Severe Hypoglycemia Requiring Medical Intervention in a Large Cohort of Adults With Diabetes Receiving Care in U.S. Integrated Health Care Delivery Systems: 2005–2011. Diabetes Care 2016;39:363–370. Diabetes Care 2017;40:e26
por: Pathak, Ram D., et al.
Publicado: (2017)

Erratum. Mitigating Cardiovascular Risk in Type 2 Diabetes With Antidiabetes Drugs: A Review of Principal Cardiovascular Outcome Results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 Trials. Diabetes Care 2017;40:821–831
por: Kaul, Sanjay
Publicado: (2018)

Erratum. Regression to Normal Glucose Regulation in American Indians and Alaska Natives of a Diabetes Prevention Program. Diabetes Care 2019;42:1209–1216
por: Pratte, Katherine A., et al.
Publicado: (2019)

Erratum. Use of Sodium–Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic Ketoacidosis. Diabetes Care 2020;43:90–97
por: Hampp, Christian, et al.
Publicado: (2020)

Erratum. Application of Zone Model Predictive Control Artificial Pancreas During Extended Use of Infusion Set and Sensor: A Randomized Crossover-Controlled Home-Use Trial. Diabetes Care 2017;40:1096–1102
por: Forlenza, Gregory P., et al.
Publicado: (2017)

Effects of Genetic Variants Previously Associated with Fasting Glucose and Insulin in the Diabetes Prevention Program
por: Florez, Jose C., et al.
Publicado: (2012)

Erratum. GLP-1 Receptor in Pancreatic α-Cells Regulates Glucagon Secretion in a Glucose-Dependent Bidirectional Manner. Diabetes 2019;68:34–44
por: Zhang, Yanqing, et al.
Publicado: (2020)

Erratum. Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes. Diabetes 2013;62:3224–3231
por: Weil, E. Jennifer, et al.
Publicado: (2018)

Regression From Prediabetes to Normal Glucose Regulation and Prevalence of Microvascular Disease in the Diabetes Prevention Program Outcomes Study (DPPOS)
por: Perreault, Leigh, et al.
Publicado: (2019)

Regression From Prediabetes to Normal Glucose Regulation Is Associated With Reduction in Cardiovascular Risk: Results From the Diabetes Prevention Program Outcomes Study
por: Perreault, Leigh, et al.
Publicado: (2014)

Erratum. Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders. Diabetes Care 2016;39:808–815
por: Steven, Sarah, et al.
Publicado: (2018)

Erratum. Weight Loss After Bariatric Surgery Reverses Insulin-Induced Increases in Brain Glucose Metabolism of the Morbidly Obese. Diabetes 2013;62:2747–2751
por: Tuulari, Jetro J., et al.
Publicado: (2017)

Erratum. miRNA Regulation of the Hyperproliferative Phenotype of Vascular Smooth Muscle Cells in Diabetes. Diabetes 2018;67:2554–2568
por: Torella, Daniele, et al.
Publicado: (2020)

Erratum. Genetic Disruption of Adenosine Kinase in Mouse Pancreatic β-Cells Protects Against High-Fat Diet–Induced Glucose Intolerance. Diabetes 2017;66:1928–1938
por: Navarro, Guadalupe, et al.
Publicado: (2017)

Direct Effects of Exendin-(9,39) and GLP-1-(9,36)amide on Insulin Action, β-Cell Function, and Glucose Metabolism in Nondiabetic Subjects. Diabetes 2013;62:2752–2756
por: Sathananthan, M, et al.
Publicado: (2013)

Identification of metabolic modifiers that underlie phenotypic variations in energy-balance regulation. Diabetes 2011;60:726–734
por: Chang, CL, et al.
Publicado: (2013)

Erratum. Changes in Screening Practices for Prediabetes and Diabetes Since the Recommendation for Hemoglobin A(1c) Testing. Diabetes Care 2019;42:576–584
por: Evron, Joshua M., et al.
Publicado: (2020)

Circulating sex hormone binding globulin levels are modified with intensive lifestyle intervention, but their changes did not independently predict diabetes risk in the Diabetes Prevention Program
por: Aroda, Vanita R, et al.
Publicado: (2020)

The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study
por: Herrington, William G, et al.
Publicado: (2019)

Erratum. Pathophysiological Mechanism of Bone Loss in Type 2 Diabetes Involves Inverse Regulation of Osteoblast Function by PGC-1α and Skeletal Muscle Atrogenes: AdipoR1 as a Potential Target for Reversing Diabetes-Induced Osteopenia. Diabetes 2015;64:2609–2623
por: Khan, Mohd. Parvez, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nc3l8o67t7imut632e889lcmk4